PMID: 754694Jan 1, 1978Paper

The effect of dipyridamole on coagulation status in stenocardia

Bilten za hematologiju i transfuziju
P FicovićZ Grgić

Abstract

The laboratory examination of Dipyridamole concerning its antiaggregation effect is presented in the paper. Thirty patients with coronary insufficiency have been taking Dipyridamole for one year. The average dosage was four pills à 75 mg of Dipyridamole a day. The aggregation and adhesion of the platelets with the examined patients was checked before and during the treatment. The inhibition platelet aggregation with Dipyridamole has been confirmed in vitro.

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Methods and Findings in Experimental and Clinical Pharmacology
S E AkopovE S Gabrielian
Biulleten' eksperimental'noĭ biologii i meditsiny
E S Gabrielian, E A Amroian
© 2021 Meta ULC. All rights reserved